|
Code
|
0395E
|
|
MA number
|
16/0055/22-S
|
|
Product Form:
|
tbl flm 196x2,5 mg (blis.Al/PVC/PVDC)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
Reddy Holding GmbH, Germany
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B01 |
ANTITHROMBOTIC AGENTS |
| B01A |
ANTITHROMBOTIC AGENTS |
| B01AF |
Direct factor Xa inhibitors |
| B01AF01 |
Rivaroxaban |
|
|
Shelf life:
|
36 |
|
Container:
|
blister Al/PVC/PVDC
|
|
Route of admin.:
|
Oral use
|
SPC_Rivaroxaban Reddy 2,5 mg tbl flm_02.2024.pdf
